mTOR Signaling at the Crossroad between Metazoan Regeneration and Human Diseases

Area of Science:

• Regenerative Medicine
• Molecular Biology
• Evolutionary Biology

Background:

• Tissue damage and organ dysfunction present significant challenges in human disease.
• The mechanistic/mammalian target of rapamycin (mTOR) pathway is a key regulator of cellular processes like growth, proliferation, and differentiation.
• mTOR signaling influences critical regenerative mechanisms, including stem cell maintenance and autophagy.

Purpose of the Study:

• To review the role of mTOR signaling in tissue regeneration across diverse animal models.
• To explore mTOR as a potential therapeutic target for promoting organ repair.
• To investigate how species-specific mTOR modulation impacts the evolution of regenerative capabilities.

Main Methods:

• Literature review of studies investigating mTOR's role in regeneration.
• Analysis of various animal models with modulated mTOR pathways.
• Comparative analysis of regenerative processes across different metazoan species.

Main Results:

• mTOR signaling is integral to reparative regeneration in numerous tissues, including axons, muscle, liver, epithelia, and kidneys.
• Modulation of the mTOR pathway in animal models demonstrates its potential to enhance regenerative capacity.
• Species-specific differences in mTOR activity correlate with the conservation or loss of regenerative abilities.

Conclusions:

• The mTOR pathway is a critical regulator of tissue regeneration with broad implications across the animal kingdom.
• Targeting mTOR presents a viable therapeutic strategy for improving organ repair in humans.
• Studying mTOR in diverse species provides insights into both applied medicine and evolutionary biology regarding regeneration.